Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval

People with moderate-to-severe atopic dermatitis, the most common form of eczema, don’t always get adequate relief from topical treatments like steroid creams and ointments. Now they have a new option: The U.S. Food and Drug Administration (FDA) just approved Ebglyss (lebrikizumab-lbkz), a biologic treatment for adults and children ages 12 years and older. This once-a-month […]

Agentic AI Set To Transform Business Operations, Decision-Making

While the technology behind AI-powered chatbots quickly captured the public imagination, an even more powerful application of generative artificial intelligence has been creating a buzz among business leaders. It’s called agentic AI. “This innovative technology is not just another industry buzzword; it’s a paradigm shift that’s poised to redefine the boundaries of AI capabilities,” tech […]

Back To Top